You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
AstraZeneca
McKesson
Harvard Business School

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for RFC Lenders of Texas, LLC v. The Progressive Corporation (E.D. Tex. 2019)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

RFC Lenders of Texas, LLC v. The Progressive Corporation (E.D. Tex. 2019)

Docket   Start Trial Date Filed 2019-10-04
Court District Court, E.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To Amos Louis Mazzant III
Jury Demand Plaintiff Referred To
Parties PROGRESSIVE CASUALTY INSURANCE CO.; RFC LENDERS OF TEXAS, LLC; THE PROGRESSIVE CORPORATION
Patents 10,004,679; 10,286,004; 10,286,008; 10,603,383; 10,603,387; 6,387,383; 6,544,555; 6,727,286; 7,727,550; 7,727,570; 8,003,679; 8,003,681; 8,008,335; 8,021,335; 8,383,678; 8,664,215; 8,679,544
Attorneys James A Collins; Jennifer Parker Ainsworth; Michael S. Weinstein; Ronald William Burns , Jr
Firms Benesch Friedlander Coplan & Aronoff - Cleveland; Benesch, Friedlander, Coplan & Aronoff LLP - Chicago; RW Burns & Co PLLC - Frisco
Link to Docket External link to docket
Small Molecule Drugs cited in RFC Lenders of Texas, LLC v. The Progressive Corporation
Biologic Drugs cited in RFC Lenders of Texas, LLC v. The Progressive Corporation

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for RFC Lenders of Texas, LLC v. The Progressive Corporation (E.D. Tex. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-05-27 33 ~Util - Terminate Motions AND Order AND Memorandum & Opinion Corporation 4 October 2019 4:19-cv-00727-ALM Patent Plaintiff District…Dismiss RFC's Amended Complaint for Patent Infringement (Dkt. 10 )filed before Plaintiff amended its …Dismiss RFC’s Amended Complaint for Patent Infringement (Dkt. #10)—filed before Plaintiff amended its …pleader is entitled to relief.’” Iqbal, 556 U.S. at 679 (quoting FED. R. CIV. P. 8(a)(2)). In Iqbal…experience and common sense.” Iqbal, 556 U.S. at 679. Thus, “[t]o survive a motion to dismiss, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
Merck
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.